Key facts
- Levee Medical’s last known valuation is $19.6M (Aug 2022).
- It has raised $22.9M across 5 recorded rounds; the latest was Early Stage VC ($6.5M) in Jul 2024.
- Notable investors include Wexford Capital.
- Levee Medical has filed 6 Form Ds with the SEC since 2022, most recently Nov 2025 ($4.5M sold to 57 investors).
- Status: Privately Held (backing).
Investors
1- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Levee Medical
Funding rounds
5 roundsAbout Levee Medical
Developer of urological devices designed to improve recovery outcomes post-prostatectomy. The company's devices support and stabilize the post-operative bladder neck and urethra following prostatectomy to accelerate the return of continence and reduce the overall risk of chronic incontinence, enabling patients to regain continence sooner after surgery and reduce the overall risk of chronic incontinence.
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 2018
- Employees
- 8
- Website
- leveemedical.com/
- Ownership
- Privately Held (backing)
Levee Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Levee Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Levee Medical in its N-PORT filings yet. We sweep new filings monthly.